These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 11390476)
1. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens. Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476 [TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. Tabi Z; Moutaftsi M; Borysiewicz LK J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411 [TBL] [Abstract][Full Text] [Related]
3. The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1. Blake N; Haigh T; Shaka'a G; Croom-Carter D; Rickinson A J Immunol; 2000 Dec; 165(12):7078-87. PubMed ID: 11120837 [TBL] [Abstract][Full Text] [Related]
4. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells. Bonini C; Lee SP; Riddell SR; Greenberg PD J Immunol; 2001 Apr; 166(8):5250-7. PubMed ID: 11290810 [TBL] [Abstract][Full Text] [Related]
5. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison. Storni T; Bachmann MF J Immunol; 2004 May; 172(10):6129-35. PubMed ID: 15128799 [TBL] [Abstract][Full Text] [Related]
6. A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors. Foster AE; Bradstock KF; Sili U; Marangolo M; Rooney CM; Gottlieb DJ Biol Blood Marrow Transplant; 2004 Nov; 10(11):761-71. PubMed ID: 15505607 [TBL] [Abstract][Full Text] [Related]
7. Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide. Einsele H; Rauser G; Grigoleit U; Hebart H; Sinzger C; Riegler S; Jahn G Cytotherapy; 2002; 4(1):49-54. PubMed ID: 11953041 [TBL] [Abstract][Full Text] [Related]
8. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells. Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339 [TBL] [Abstract][Full Text] [Related]
9. Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals. Kreiter S; Selmi A; Diken M; Sebastian M; Osterloh P; Schild H; Huber C; Türeci O; Sahin U J Immunol; 2008 Jan; 180(1):309-18. PubMed ID: 18097032 [TBL] [Abstract][Full Text] [Related]
10. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation. Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296 [TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. Kern F; Bunde T; Faulhaber N; Kiecker F; Khatamzas E; Rudawski IM; Pruss A; Gratama JW; Volkmer-Engert R; Ewert R; Reinke P; Volk HD; Picker LJ J Infect Dis; 2002 Jun; 185(12):1709-16. PubMed ID: 12085315 [TBL] [Abstract][Full Text] [Related]
12. B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen. Sun Q; Burton RL; Dai LJ; Britt WJ; Lucas KG J Immunol; 2000 Oct; 165(7):4105-11. PubMed ID: 11034422 [TBL] [Abstract][Full Text] [Related]
13. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy. Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388 [TBL] [Abstract][Full Text] [Related]
14. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading. Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483 [TBL] [Abstract][Full Text] [Related]
15. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression. Wehler TC; Karg M; Distler E; Konur A; Nonn M; Meyer RG; Huber C; Hartwig UF; Herr W J Immunol Methods; 2008 Nov; 339(1):23-37. PubMed ID: 18760281 [TBL] [Abstract][Full Text] [Related]
16. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains. Machy P; Serre K; Baillet M; Leserman L J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652 [TBL] [Abstract][Full Text] [Related]
17. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses. Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490 [TBL] [Abstract][Full Text] [Related]
18. Multiple paths for activation of naive CD8+ T cells: CD4-independent help. Wang B; Norbury CC; Greenwood R; Bennink JR; Yewdell JW; Frelinger JA J Immunol; 2001 Aug; 167(3):1283-9. PubMed ID: 11466344 [TBL] [Abstract][Full Text] [Related]
19. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. Tobian AA; Canaday DH; Boom WH; Harding CV J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266 [TBL] [Abstract][Full Text] [Related]
20. CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects. Slezak SL; Bettinotti M; Selleri S; Adams S; Marincola FM; Stroncek DF J Transl Med; 2007 Mar; 5():17. PubMed ID: 17391521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]